SNC
DGX icon

Stifel Nicolaus & Co’s Quest Diagnostics DGX Stock Holding History

Stifel Nicolaus & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.26M Buy
36,554
+3,926
+12% +$235K 0.04% 427
2013
Q2 		$1.98M Buy
+32,628
New +$1.94M 0.04% 433

Other funds holding DGX

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Nicolaus & Co's DGX Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Quest Diagnostics (DGX) stake by 12% in Q3 2013, buying an estimated $235K and bringing the position to 36,554 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #427.

Stifel Nicolaus & Co first reported a position in DGX in Q2 2013 and has held it in 2 quarters since. 425 funds tracked by Wall St. Rank hold DGX as of Q3 2013.

  • Stifel Nicolaus & Co held 36,554 shares of Quest Diagnostics worth $2.26M as of Q3 2013.
  • Stifel Nicolaus & Co bought 3,926 Quest Diagnostics shares in Q3 2013, an estimated $235K.
  • Quest Diagnostics made up 0.04% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #427 holding.
  • Stifel Nicolaus & Co first reported a position in Quest Diagnostics in Q2 2013 and has held it in 2 quarters since.
  • 425 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.